Methadone Withdrawal Symptoms with Nevirapine and Efavirenz

Guibert A Furlan V Martino J Taburet AM . In vitro effect of HIV protease inhibitors on methadone metabolism. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 28–October 1, 1997.

Iribarne C Berthou F Carlhant D Dreano Y Picard D Lohezic F Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors. Drug Metab Dispos 1998,26:257–60.

Begaud B Evreux JC Jouglard J Lagier G . Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 1985;37:249–63.

Kreek MJ Garfield JW Gutjahr CL Giusti LM . Rifampin-induced methadone withdrawal. N Engl J Med 1976;294:1104–6.

Rainey PM McCance EF Mitchel SM Jatlow P Andrews L Friedland G . Interaction of methadone with didanosine and stavudine (abstract). Presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, January 31–February 4, 1999.

Patel SS Benfield P . Nevirapine. Clin Immunother 1996;6:307–17.

Altice FL Friedland GH Coouney E . Nevirapine-induced opiate withdrawal among injection drug users with HIV infection receiving methadone. AIDS 1999;8:957–62.

Otero MJ Fuertes A Sanchez R Luna G . Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: An alert. AIDS 1999;8:1004–5.

Tashima K Bose T Gormley J Sousa H Flanigan TP . The potential impact of efavirenz on methadone maintenance (abstract). Presented at the 9th European Conference of Clinical Microbiology and Infectious Diseases. Berlin, Germany, March 21–24, 1999.